Sivelestat is a highly specific NE inhibitor with beneficial effects in various conditions induced by acute inflammation and is currently the only drug approved for the treatment of ALI/ARDS worldwide (Kawabata et al., 2002; Sakashita et al., 2007; Takemasa et al., 2012). This evidence concerns the gene ELANE and acute respiratory distress syndrome.